GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nipro Corp (TSE:8086) » Definitions » Cyclically Adjusted Revenue per Share

Nipro (TSE:8086) Cyclically Adjusted Revenue per Share : 円2,588.34 (As of Dec. 2023)


View and export this data going back to 1996. Start your Free Trial

What is Nipro Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Nipro's adjusted revenue per share for the three months ended in Dec. 2023 was 円832.754. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円2,588.34 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Nipro's average Cyclically Adjusted Revenue Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Nipro was 7.70% per year. The lowest was 5.50% per year. And the median was 6.40% per year.

As of today (2024-05-24), Nipro's current stock price is 円1173.50. Nipro's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was 円2,588.34. Nipro's Cyclically Adjusted PS Ratio of today is 0.45.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Nipro was 0.99. The lowest was 0.41. And the median was 0.61.


Nipro Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Nipro's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nipro Cyclically Adjusted Revenue per Share Chart

Nipro Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,946.63 2,043.71 2,203.40 2,433.24 -

Nipro Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,433.24 2,487.01 2,543.01 2,588.34 -

Competitive Comparison of Nipro's Cyclically Adjusted Revenue per Share

For the Medical Instruments & Supplies subindustry, Nipro's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nipro's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nipro's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Nipro's Cyclically Adjusted PS Ratio falls into.



Nipro Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Nipro's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=832.754/106.8000*106.8000
=832.754

Current CPI (Dec. 2023) = 106.8000.

Nipro Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 462.003 95.700 515.590
201406 445.797 98.000 485.828
201409 467.657 98.500 507.064
201412 505.632 97.900 551.599
201503 501.197 97.900 546.760
201506 519.526 98.400 563.876
201509 539.008 98.500 584.427
201512 557.104 98.100 606.511
201603 545.305 97.900 594.878
201606 477.002 98.100 519.305
201609 475.601 98.000 518.308
201612 503.510 98.400 546.493
201703 488.485 98.100 531.806
201706 510.544 98.500 553.564
201709 514.502 98.800 556.162
201712 578.004 99.400 621.034
201803 553.244 99.200 595.630
201806 562.293 99.200 605.372
201809 575.247 99.900 614.979
201812 625.108 99.700 669.624
201903 583.098 99.700 624.623
201906 609.347 99.800 652.087
201909 626.558 100.100 668.495
201912 632.830 100.500 672.500
202003 648.663 100.300 690.700
202006 604.501 99.900 646.253
202009 629.214 99.900 672.673
202012 659.214 99.300 709.004
202103 701.883 99.900 750.361
202106 723.502 99.500 776.583
202109 761.013 100.100 811.950
202112 691.001 100.100 737.252
202203 682.020 101.100 720.472
202206 694.861 101.800 728.990
202209 719.684 103.100 745.512
202212 792.591 104.100 813.148
202303 754.839 104.400 772.192
202306 763.853 105.200 775.471
202309 789.105 106.200 793.563
202312 832.754 106.800 832.754

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Nipro  (TSE:8086) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Nipro's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1173.50/2588.34
=0.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Nipro was 0.99. The lowest was 0.41. And the median was 0.61.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Nipro Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Nipro's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Nipro (TSE:8086) Business Description

Industry
Traded in Other Exchanges
Address
3-9-3 Honjo-Nishi Kita-ku, Osaka, JPN, 531-8510
Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.

Nipro (TSE:8086) Headlines

No Headlines